45:29
Get The 411 On Cannabinoid Pharmacology 101
-
Video
-
Audio
-
Table of contents
-
Video
-
Audio
- Description
- Transcript
- Discussion
About speakers
The founder of the Upward Cannabis Kitchen, Carlton has a passion for crafting high quality cannabis products. Through the development of a tea based cannabis beverage line, Carlton was able to explore ancillary endocannabinoid modulators and the wide world of botanicals and brings this passion into their work as a cook, consultant, and caregiver. When not developing personalized formulations, Carlton helps their mother – Dr. Melanie Bone – with her cannabis wellness practice in South Florida. With the list time remaining, Carlton enjoys volunteering with a local Harm Reduction Group and making art and wonderful memories with friends.
View the profileDr. Cohin Kakar comes from a background in the pharmaceutical industry, working with various Fortune 150 companies in roles ranging from clinical trial management to global medical affairs for over 10 years. Most notably, Dr. Kakar served on the medical launch teams for some of the biggest commercial drugs globally, with a specialty in inflammation and immunology. Lastly, Dr. Kakar is a published author in Oncology and Cannabis with more publications underway.
View the profileRealizing the benefits of cannabis for patients with cancer and inflammatory bowel disease, Dr. Adam Abodeely, MD, MBA, FACS, FASCRS expanded his medical cannabis practice to include patients with a variety of medical ailments. Dedicated to advancing the science and education of cannabinoid-bases therapies, he has a special interest in formulating products that capture the unique benefits of cannabinoids, terpenes and other natural ingredients to provide optimal synergy and interaction with the human endocannabinoid system.
View the profileBill Fisher is the founder and Board Chairman of Diverse Biotech, a biopharmaceutical research company focused on new medical discoveries and the development of new molecules for the treatment of disease. Bill is a creative entrepreneur and executive with over 25 years experience in building businesses in both domestic and global markets. Diverse Biotech executives are some of the most experienced executives from the Pharmaceutical Industry including Merck, Johnson & Johnson, Purdue and many more.
View the profileAbout the talk
Cannabinoids are wonderful compounds with one very big problem–they are lipophilic, or fat loving. This makes dosing very, very tricky. And why it’s so hard to measure cannabinoid levels in the blood and urine. The pharmacokinetics and pharmacodynamics of cannabinoids are greatly affected by various factors, such as the amount and type of food eaten in a given day, whether other substances, including medications, were taken, and how they were consumed (vape, oil, edible, etc.). For these reasons and more, despite decades of research, the best advice to offer new users remains the “start low, go slow” method, which is as unscientific as it comes. And explains why this topic remains red hot in research.
00:10 Intro
02:42 Safe approach to CBD
10:10 CBD in 10 years
18:45 Cannabinoid system
24:44 Future trends
38:49 Applications
40:00 Q&A
Included in subscription
Share
I'm your moderator I get the Lovely opportunity to work with my mom doctor Melanie Bone cannabis position based in South Florida and work with a cannabis company out in Oregon today. We have a wonderful group of some of the most qualified folks. I know to speak about a really great topic cannabinoid pharmacology is a huge way of understanding the ways that products and body interact in order to create cannabinoid therapies in medicine and we'll learn a lot about the intricacies of those interactions’ specific products and
bodies before that with such a panelist introduced himself, so we know who's talking today. Hi everyone. My name is Cohin Kakar and I oversee the marketing at our company The Anthos Group our Flagship brand is Saito CBD. My background is I'm a pharmacist and my background in my career is I've been working the big pharmaceutical industry for over 10 years before coming into the CD space. Morning, my name is Adam Abodeely I'm a General and Colorectal Surgeon in Lake Placid New York. I've been involved in the Cannabis business incorporating cannabis therapy into treatment protocols
for patients now for about seven years. I'm also the CMO and Co-founder of a CBD company ReserveMD Health, and I'm also currently the Chief Medical Director here for the cannabinoid industry Association for educational platforms. Jim Taylor board-certified anesthesiologist and pain physician got involved in CBD about two years ago with the opioid crisis. We have many patients requiring narcotics and tried to bring it into our practice to reduce that dependency on narcotics we've learned so much over this last two years of
what this stuff does and doesn't do so, I'm mainly a clinician coming here to share information. Morning, everyone Bill Fisher. I am the Board Chairman of a pharmaceutical company Diverse Biotech and we have some novel new drugs that incorporate the